Gary D. Kruh
- Oncology top 0.5%
- Molecular Biology top 2%
- Pediatrics, Perinatology and Child Health top 0.5%
- Surgery top 5%
- Infectious Diseases top 2%
- Co-authors
- Martin G. BelinskyZhe‐Sheng ChenKun Hee LeeHao ZengElizabeth Hopper-BorgeIrina ShchavelevaYanping GuoPhilip A. Rea
- Topics
- Drug Transport and Resistance Mechanisms (42 papers)Pharmacological Effects and Toxicity Studies (20 papers)HIV/AIDS drug development and treatment (11 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Gary D. Kruh
70 papers receiving 6.8k citations
Peers
Comparison fields: 5 of 113
- Oncology 4.3k
- Molecular Biology 3.0k
- Pediatrics, Perinatology and Child Health 1.5k
- Surgery 918
- Infectious Diseases 806
Countries citing papers authored by Gary D. Kruh
This map shows the geographic impact of Gary D. Kruh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Kruh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Kruh more than expected).
Fields of papers citing papers by Gary D. Kruh
This network shows the impact of papers produced by Gary D. Kruh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Kruh. The network helps show where Gary D. Kruh may publish in the future.
Co-authorship network of co-authors of Gary D. Kruh
This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Kruh. A scholar is included among the top collaborators of Gary D. Kruh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Kruh. Gary D. Kruh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 59 | |
| 2 | 13 | |
| 3 | 111 | |
| 4 | 179 | |
| 5 | 31 | |
| 6 | 111 | |
| 7 | Analysis of the contribution of MRP3 to in vivo chemosensitivity using knock out mice. | 1 |
| 8 | 107 | |
| 9 | 436 | |
| 10 | 484 | |
| 11 | 142 | |
| 12 | Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). | 201 |
| 13 | 多剤耐性蛋白質(MRP)3とMRP1によるメトトレキセート(MTX)と葉酸塩の輸送 ポリグルタミル化がMTX輸送に及ぼす効果 | 1 |
| 14 | 129 | |
| 15 | 325 | |
| 16 | 2 | |
| 17 | Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. | 137 |
| 18 | Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells. | 65 |
| 19 | Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. | 16 |
| 20 | 78 |
About Gary D. Kruh
Gary D. Kruh is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Hematology, having authored 70 papers that have together received 6.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (42 papers), Pharmacological Effects and Toxicity Studies (20 papers) and HIV/AIDS drug development and treatment (11 papers). The work is most often cited by research in Oncology (4.3k citations), Pediatrics, Perinatology and Child Health (1.5k citations) and Pharmacology (431 citations). Gary D. Kruh has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Martin G. Belinsky, Zhe‐Sheng Chen, Kun Hee Lee, Hao Zeng, Elizabeth Hopper-Borge, Irina Shchaveleva, Yanping Guo, Philip A. Rea, Elena Kotova and Erica A. Golemis. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.